BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25239644)

  • 21. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
    Foss-Skiftesvik J; Li S; Rosenbaum A; Hagen CM; Stoltze UK; Ljungqvist S; Hjalmars U; Schmiegelow K; Morimoto L; de Smith AJ; Mathiasen R; Metayer C; Hougaard D; Melin B; Walsh KM; Bybjerg-Grauholm J; Dahlin AM; Wiemels JL
    Neuro Oncol; 2023 Sep; 25(9):1709-1720. PubMed ID: 36810956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
    Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
    Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
    Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
    J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
    Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
    Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
    Rudolph A; Hein R; Lindström S; Beckmann L; Behrens S; Liu J; Aschard H; Bolla MK; Wang J; Truong T; Cordina-Duverger E; Menegaux F; Brüning T; Harth V; ; Severi G; Baglietto L; Southey M; Chanock SJ; Lissowska J; Figueroa JD; Eriksson M; Humpreys K; Darabi H; Olson JE; Stevens KN; Vachon CM; Knight JA; Glendon G; Mulligan AM; Ashworth A; Orr N; Schoemaker M; Webb PM; ; ; Guénel P; Brauch H; Giles G; García-Closas M; Czene K; Chenevix-Trench G; Couch FJ; Andrulis IL; Swerdlow A; Hunter DJ; Flesch-Janys D; Easton DF; Hall P; Nevanlinna H; Kraft P; Chang-Claude J;
    Endocr Relat Cancer; 2013 Dec; 20(6):875-87. PubMed ID: 24080446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma.
    Burdon KP; Crawford A; Casson RJ; Hewitt AW; Landers J; Danoy P; Mackey DA; Mitchell P; Healey PR; Craig JE
    Ophthalmology; 2012 Aug; 119(8):1539-45. PubMed ID: 22521085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
    Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
    Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke.
    Gschwendtner A; Bevan S; Cole JW; Plourde A; Matarin M; Ross-Adams H; Meitinger T; Wichmann E; Mitchell BD; Furie K; Slowik A; Rich SS; Syme PD; MacLeod MJ; Meschia JF; Rosand J; Kittner SJ; Markus HS; Müller-Myhsok B; Dichgans M;
    Ann Neurol; 2009 May; 65(5):531-9. PubMed ID: 19475673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
    Zhao XK; Mao YM; Meng H; Song X; Hu SJ; Lv S; Cheng R; Zhang TJ; Han XN; Ren JL; Qi YJ; Wang LD
    PLoS One; 2017; 12(5):e0177504. PubMed ID: 28542283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLC-ε1 gene polymorphisms significantly enhance the risk of esophageal squamous cell carcinoma in individuals with a family history of upper gastrointestinal cancers.
    Zhou RM; Li Y; Wang N; Liu BC; Chen ZF; Zuo LF
    Arch Med Res; 2012 Oct; 43(7):578-84. PubMed ID: 23079034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study.
    Kunnas T; Piesanen J; Nikkari ST
    Genet Test Mol Biomarkers; 2018 May; 22(5):327-330. PubMed ID: 29791233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.
    Haryono SJ; Datasena IG; Santosa WB; Mulyarahardja R; Sari K
    Asian Pac J Cancer Prev; 2015; 16(6):2231-5. PubMed ID: 25824743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
    Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
    Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of breast cancer susceptibility variants with risk of pancreatic cancer.
    Couch FJ; Wang X; McWilliams RR; Bamlet WR; de Andrade M; Petersen GM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3044-8. PubMed ID: 19843670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population.
    Akan G; Kisenge P; Sanga TS; Mbugi E; Adolf I; Turkcan MK; Janabi M; Atalar F
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):33-43. PubMed ID: 31472045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Tumour Biol; 2014 Nov; 35(11):11667-76. PubMed ID: 25139097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China.
    Shen FF; Yue WB; Zhou FY; Pan Y; Zhao XK; Jin Y; Song X; Li B; Han XN; Tang S; Li Y; Yuan G; Chen LS; Liu YL; Hu YL; Li XM; Ren JL; Wang LD
    PLoS One; 2014; 9(3):e90438. PubMed ID: 24595008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-associated polymorphisms in 9p21 are not associated with extreme longevity.
    Congrains A; Kamide K; Hirose N; Arai Y; Oguro R; Nakama C; Imaizumi Y; Kawai T; Kusunoki H; Yamamoto H; Onishi-Takeya M; Takeya Y; Yamamoto K; Sugimoto K; Akasaka H; Saitoh S; Miura T; Awata N; Kato N; Katsuya T; Ikebe K; Gondo Y; Rakugi H
    Geriatr Gerontol Int; 2015 Jun; 15(6):797-803. PubMed ID: 25257646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.